Literature DB >> 1921431

Angiographic assessment of graft patency after coronary endarterectomy.

J Goldstein1, E Cooper, A Saltups, J Boxall.   

Abstract

Fifty-one consecutive patients underwent 68 manual core endarterectomies between April 1985 and May 1987. There were 42 men and nine women, mean age 60 years (range 39 to 81). All patients underwent coronary bypass grafting alone. There were no reoperations. There was one operative death (2%). Forty patients consented to early (mean 19 days) and 27 to late (mean 19 months) repeat angiography. At the early restudy 47 of 52 (90%) grafts to endarterectomized vessels were patent. This rate fell to 27 of 42 (64%) at late restudy. There was considerable variation in the angiographic appearance of the endarterectomized vessels, ranging from a large caliber, smooth walled vessel to an attenuated vessel with irregular walls. In general, there was a tendency toward "shrinkage" of these vessels by the late restudy, suggesting fibrosis in the walls. We conclude that, although endarterectomy can be done on most atheromatous vessels with excellent early graft patency, these vessels tend to show an accelerated deterioration with time, resulting in a low late patency rate. We suggest that the procedure be reserved for vessels that are truly inoperable by other means and only for vessels that supply a coronary bed of at least moderate size.

Entities:  

Mesh:

Year:  1991        PMID: 1921431

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  2 in total

Review 1.  Coronary endarterectomy for the diffusely diseased coronary artery.

Authors:  Kosaku Nishigawa; Toshihiro Fukui; Shuichiro Takanashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-10

2.  Coronary flow reserve in patients with left anterior descending artery-left internal mammary artery long patch plasty anastomosis: a prospective study.

Authors:  Ismail Haberal; Onur Gurer; Deniz Ozsoy; Esra Erturk
Journal:  J Cardiothorac Surg       Date:  2015-04-02       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.